Onconova Therapeutics Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Onconova Therapeutics operates as a clinical-stage biopharmaceutical company pursuing new therapies for cancer. The firm is based in Newtown, Pennsylvania, and functions as a small player within the biotechnology research sector. In 2023, the company added Victor Moyo to its leadership team as Chief Medical Officer. Public updates from the company in 2023 include information about Narazaciclib trials, reflecting ongoing clinical program activity. It trades on Nasdaq under the ticker ONTX.